These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24801909)

  • 41. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wip1 phosphatase-deficient mice exhibit defective T cell maturation due to sustained p53 activation.
    Schito ML; Demidov ON; Saito S; Ashwell JD; Appella E
    J Immunol; 2006 Apr; 176(8):4818-25. PubMed ID: 16585576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.
    He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ
    Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair.
    Nguyen TA; Slattery SD; Moon SH; Darlington YF; Lu X; Donehower LA
    DNA Repair (Amst); 2010 Jul; 9(7):813-23. PubMed ID: 20451471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. H19/miR-675-5p Targeting SFN Enhances the Invasion and Metastasis of Nasalpharyngeal Cancer Cells.
    Zhang T; Lei F; Jiang T; Xie L; Huang P; Li P; Huang Y; Tang X; Gong J; Lin Y; Cheng A; Huang W
    Curr Mol Pharmacol; 2019; 12(4):324-333. PubMed ID: 31677258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clusterin induced by N,N'-Dinitrosopiperazine is involved in nasopharyngeal carcinoma metastasis.
    Li Y; Lu J; Zhou S; Wang W; Tan G; Zhang Z; Dong Z; Kang T; Tang F
    Oncotarget; 2016 Feb; 7(5):5548-63. PubMed ID: 26716898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrative analysis of miRNAs-mRNAs reveals that miR-182 up-regulation contributes to proliferation and invasion of nasopharyngeal carcinoma by targeting PTEN.
    Shi Z; Wang R; Huang L; Chen X; Xu M; Zha D; Ma Y
    Aging (Albany NY); 2020 Jun; 12(12):11568-11578. PubMed ID: 32541092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.
    Peng H; Gong PG; Li JB; Cai LM; Yang L; Liu YY; Yao KT; Li X
    J Transl Med; 2016 May; 14(1):131. PubMed ID: 27170279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased Expression of Cullin 3 in Nasopharyngeal Carcinoma and Knockdown Inhibits Proliferation and Invasion.
    Zeng R; Tan G; Li W; Ma Y
    Oncol Res; 2018 Jan; 26(1):111-122. PubMed ID: 28429677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
    Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinoma.
    Jiang L; Wang P; Chen H
    Ups J Med Sci; 2014 Nov; 119(4):324-32. PubMed ID: 25231007
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LncRNA HOTAIR contributes to the tumorigenesis of nasopharyngeal carcinoma via up-regulating FASN.
    Ma DD; Yuan LL; Lin LQ
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5143-5152. PubMed ID: 29228426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma.
    Liu Z; Li L; Yang Z; Luo W; Li X; Yang H; Yao K; Wu B; Fang W
    BMC Cancer; 2010 Jun; 10():270. PubMed ID: 20534121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells.
    Huang S; Li X; Zhu H
    Med Sci Monit; 2016 Nov; 22():4330-4337. PubMed ID: 27840403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
    Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L
    Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.
    Jiang L; Wang P; Chen L; Chen H
    Int J Clin Exp Pathol; 2014; 7(9):5450-60. PubMed ID: 25337187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.
    Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X
    Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
    Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
    Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual PI3K/mTOR inhibitors, GSK2126458 and PKI-587, suppress tumor progression and increase radiosensitivity in nasopharyngeal carcinoma.
    Liu T; Sun Q; Li Q; Yang H; Zhang Y; Wang R; Lin X; Xiao D; Yuan Y; Chen L; Wang W
    Mol Cancer Ther; 2015 Feb; 14(2):429-39. PubMed ID: 25504751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.